一般描述
产品来源:小鼠,在大肠埃希菌中表达
干扰素-γ(IFN-γ)是由活化的NK细胞和CD4+TCRα/β+,CD8+TCRα/β+和TCRγ/δ+T细胞产生的调节蛋白。 IFN-γ的生物活性包括与一类高亲和力受体的特异性结合。 此外,IFN-γ可以升级淋巴样细胞功能的数量,包括巨噬细胞,NK细胞和中性粒细胞的抗微生物和抗肿瘤反应。重组小鼠IFN-γ是一种含134个氨基酸的蛋白,预测分子量为15.6 kDa。在大肠杆菌发酵过程中由于蛋白水解裂解出现C末端截短,并产生一种经质谱验证为15.1 kDa的蛋白。重组小鼠IFN-γ的SDS-PAGE 分析出现一条11-12 kDa的条带,在非还原和还原条件下,该条带在11-12 kDa左右迁移。
应用
对于大多数体外应用,IFN-γ在0.1至10.0 ng/mL的浓度范围内发挥其生物活性。
生化/生理作用
用小鼠NIH 3T3细胞攻击的VSV通过细胞病变效应抑制试验确定的ED50为≤0.1 ng/ml
外形
10 mM磷酸钠、pH值7.0+25 mM NaCl经无菌过滤、冻干。
储存及稳定性
尽管冻干的蛋白质在室温下可稳定数周,但最好在 -20°C 下保存。快速旋转后,用磷酸钠,pH值8.0复溶至1 mg/mL的浓度。 进一步稀释应配成RPMI+10%FCS或5%HAS在2-8ºC保存一周或在-20ºC保存备用。自收到之日起,复溶的IFN-γ应该以未稀释的等分试样在 -20°C 下保存长达 6 个月。
法律信息
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免责声明
除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
International journal of cancer, 125(1), 189-198 (2009-04-10)
Treatment of patients with cervical cancer by conventional methods (mainly surgery, but also radiotherapy and chemotherapy) results in a significant loss in quality of life. A therapeutic DNA vaccine directed to tumor-specific antigens of the human papilloma virus (HPV) could
Scientific reports, 12(1), 22076-22076 (2022-12-22)
Enteric neuron degeneration has been observed during aging, and in individuals with metabolic dysfunction including obesity and diabetes. Honokiol, a naturally occurring compound, is an activator of Sirtuin-3 (SIRT3) that has antioxidant activity. Its role in modulating enteric neuron-specific neurodegeneration
Toxicological sciences : an official journal of the Society of Toxicology, 180(1), 148-159 (2020-12-03)
Hydroxylated chalcones are phytochemicals which are biosynthetic precursors of flavonoids and their 1,3-diaryl-prop-2-en-1-one structure is used as a scaffold for drug development. In this study, the structure-dependent activation of aryl hydrocarbon receptor (AhR)-responsive CYP1A1, CYP1B1, and UGT1A1 genes was investigated
Mediators of inflammation, 2023, 2547588-2547588 (2023-05-26)
Dihydromyricetin (DMY), a natural flavonoid compound extracted from the stems and leaves of Ampelopsis grossedentata, has been found as a potential therapeutic chemical for treating atherosclerosis. This study explores the underlying mechanism of DMY repressing M1 macrophage polarization in atherosclerosis.
Methods and protocols, 5(5) (2022-09-23)
Macrophage activation refers to the enhanced functionality of macrophages in response to endogenous or exogenous stimuli. Due to the existence of limitless stimuli and a multitude of receptors on macrophage surfaces, the nature of activation (or acquired functioning) can be
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门